AEVIS VICTORIA SA (AEVS.SW) – Publication of the Annual Report 2023

AEVIS VICTORIA SA / Key word(s): Annual Results AEVIS VICTORIA SA (AEVS.SW) – Publication of the Annual Report 2023 28-March-2024 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. Ad hoc announcement pursuant to Art. 53 LR

Fribourg, 28 March 2024

AEVIS VICTORIA SA (AEVS.SW) – Publication of the Annual Report 2023

During the year 2023, all investments of AEVIS VICTORIA SA (AEVIS) achieved significant, transformative milestones. The overall value of the holdings continued to increase, driven primarily by Swiss Medical Network, a leader in integrated healthcare in Switzerland, with the entry of the insurance group Visana into its capital. The inflationary environment, interest rates, energy costs, and the geopolitical situation weighed on their profitability, but each of the companies in which AEVIS is a shareholder managed to navigate this challenging environment and implement the necessary compensatory measures.

Swiss Medical Network with positive start into 2024
Swiss Medical Network achieved total revenues of CHF 768.7 million, taking into account the deconsolidation of Réseau de l’Arc. On a like-for like basis, revenue remained stable with organic growth of 0.3%. The operating profit at the EBITDAR level reached CHF 106.8 million, 24.1% less than in the previous year (2022: CHF 140.6 million). This corresponds to an operating margin of 16.5%. On a like-for-like basis, the operating profit amounted CHF 106.6 million compared to CHF 124.5 million a year ago. Swiss Medical Network has initiated various revenue and cost-optimization measures in order to regain the margins achieved in 2022 by 2024. Activity in January and February of 2024 showed positive effects of these measures, with turnover being around 8% above the same period in 2023 and profitability sequentially improving again.